Fluorofelbamate

Neurotherapeutics

Volumn 4, Issue 1, 2007, Pages 97-101

  Roecklein, Bryan A ^a   Sacks, Harry J ^a   Mortko, Henry ^a   Stables, James ^b  

^a MedPointe Pharmaceuticals   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

anticonvulsant; atropaldehyde; Carbamates; dicarbamates; felbamate; Felbatol; fluorofelbamate; glutathione; metabolism

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; BICUCULLINE; FELBAMATE; FLUOROFELBAMATE; PENTETRAZOLE; PICROTOXIN; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANIMAL BEHAVIOR; ANTICONVULSANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ATAXIA; BRAIN HYPOXIA; CLINICAL TRIAL; CLONIC SEIZURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG URINE LEVEL; ELECTRIC SHOCK; EPILEPSY; EPILEPTIC STATE; FOCAL EPILEPSY; GAIT DISORDER; GRAND MAL SEIZURE; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KINDLING; LOW DRUG DOSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SUBICULUM; URINARY EXCRETION;

ANIMALS; ANTICONVULSANTS; BRAIN; CLINICAL TRIALS; EPILEPSY; HUMANS; PHENYLCARBAMATES; PROPYLENE GLYCOLS;

EID: 33846222410     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2006.11.015     Document Type: Article

References (10)

1. Leppik I.E., Dreifuss F.E., Pledger G.W., et al. Felbamate for partial seizures: results of a controlled clinical trial. Neurology 41 (1991) 1785-1789
2. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 328 (1993) 29-33
3. Bourgeois B., Leppik I.E., Sackellares J.C., et al. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology 43 (1993) 693-696
4. Sachdeo R., Kramer L.D., Rosenberg A., and Sachdeo S. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurology 32 (1992) 386-392
5. Faught E., Sachdeo R.C., Remler M.P., et al. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 43 (1993) 688-692
6. Pellock J.M., Faught E., Leppik I.E., Shinnar S., and Zupanc M.L. Felbamate: consensus of current clinical experience. Epilepsy Res 71 (2006) 89-101
7. Mazarati A.M., Sofia R.D., and Wasterlain C.G. Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus. Seizure 11 (2002) 423-430
8. Wallis R.A., Panizzon K.L., Niquet J., Masaratis L., Baldwin R., and Wasterlain C.G. Neuroprotective effects of the anticonvulsant, fluorofelbamate. Epilepsia 41 suppl 7 (2000) 162
9. Thompson C.D., Kinter M.T., and Macdonald T.L. Synthesis and in vitro reactivity of 3-carbamoyl-2-phenylpropionaldehyde and 2-phenylproenal: putative reactive metabolites of felbamate. Chem Res Toxicol 9 (1996) 1225-1229
10. Parker R.J., Hartman N.R., Roecklein B.A., et al. Stability and comparative metabolism of selected felbamate metabolites and postulated fluorofelbamate metabolites by postmitochondrial suspensions. Chem Res Toxicol 18; (2005) 1842-1848